The importance of the European Foundation for Clinical Nanomedicine

The main activities of the European Foundation for Clinical Nanomedicine are threefold:

 

1. Fundraising for research and development of clinical Nanomedicine

Nanomedicine is at the edge of being applied in clinic to the treatment of the human being and therefore the need for investment into research is very high. - The foundation intends to assist to early investments that shall lead to major progress and shorten the developmental lag time in implementing translational nanomedicine and keeping Europe being a front runner in the development of nanomedicine in clinical use. During its first five years, the CLINAM-Foundation targets to raise funds of several millions of Euros in order to realise all envisaged tasks.

 

2. Establishing the European Lab space for Nanomedicine

In its study on nanomedicine the European Science Foundation shows that Europe currently takes the lead "in ultra-modern technology" in the field of nanomedicine. In order to maintain this advanced position, in Europe there is high need for labs and research spaces as a fundamental condition to facilitate innovation across Europe, assisting to be a knowledge driven economy in the global market. The European Foundation for Clinical Nanomedicine plans to realise its project of a European Research Lab Space for Clinical Nanomedicine in Basel, Switzerland. Basel is the location of many chemical and pharmaceutical companies. The town offers excellent scientific facilities with the Department of Research of the Basel University Hospital, the University Basel with its Biozentrum and private research places such as the Friedrich Miescher Institute. Basel is worldwide renown for its Swiss Nanoscience Institute (SNI) developed from the National Center of Competence in Research (NCCR) for Nanoscale Science.

 

3. Strong network with clear tasks and services

The third task is the establishment of the CLINAM-Foundation Network. Its purpose is the proactive support of development of Nanomedicine in Europe for all clinical experts in research and development of Nanomedicine including bridgework between the clinicians, academic research and the industrial and tool developing clusters. - The network interacts with the existing nanomedical structures in Europe, seeking to propagate nanomedical knowledge. The CLINAM-Network is a valuable non competing add-on for the various other initiatives in the field of Nanomedicine.

 


The Structure of the European Foundation for Clinical Nanomedicine

The European Foundation for Clinical Nanomedicine is a lean organisation and seeks to keep the administration at an utmost minimum.

 

The Team

The Foundation is governed by its Board of Trustees. In addition to that an international advisory Board drawing its members from different segments of science, society, and politics advises the officers of the Foundation on important issues.

 

The Directors

Beat Löffler M.A. is the Executive Director responsible for organisational and administrative matters. PD Dr. Patrick Hunziker is the Scientific Director and responsible for all scientific matters and contents. He also leads the research programmes.

 

The members of the board of Trustees

 

Members of the Advisory Board of the CLINAM-Foundation

We are presently inviting outstanding personalities from Science, Economy, Society and Politics to participate in the Advisory Board. The list will be available in some weeks.